Peptide Industry Statistics 2026

Because research peptides are sold without pharmaceutical oversight, a third-party Certificate of Analysis (CoA) that verifies identity and purity is the single most important trust signal a buyer can check. The PeptideTrust dataset rates 22 well-known vendors (20 currently active) against 10 weighted criteria. Here is what the market actually looks like in 2026, among the 20 active vendors.

💬 Quotable: “As of July 2026, PeptideTrust rated 20 active research-peptide vendors on 10 transparency criteria: 80% publish a Certificate of Analysis, but only 30% publish one that can be verified at the testing lab itself, and none publish a complete recall or complaint policy.”

The average transparency score is 76.4 / 100 (median 87), ranging from a high of 98 down to 30; 12 of 20 vendors have every criterion independently verified. The gap between publishing a document and publishing a document a buyer can independently verify is the defining transparency problem of the sector. Only 3 of 22 tracked vendors have an affiliate relationship with us, and the highest-scoring vendors are all independent, so the ranking is not skewed toward partners.

Sticker prices for the same peptide can look wildly different, but most of that gap is vial size and multi-vial bundles, not the underlying cost of the compound. Normalized to price per milligram, the spread across the vendors we monitor is far smaller. Figures below are as of August 2026, converted to USD, across monitored vendors and vial sizes.

💬 Quotable: “Once you normalize for vial size, BPC-157 costs roughly $6 to $11 per milligram across monitored vendors, not the 10-fold gap suggested by raw sticker prices. The apparent spread is mostly packaging, not the peptide.”

Note: per-mg figures normalize each listing by the total milligrams it contains (including multi-vial kits) and cover the vendors we track for price, not the full market. They illustrate real cost per milligram, not a recommended dose.

Peptides attract strong marketing claims. To ground our own content, every article and guide carries a curated list of primary sources. The evidence footprint of our library:

💬 Quotable: “Klow Peptide's library cites 455 unique peer-reviewed studies across 154 sourced articles and guides.”

Peptide interest is global, and reliable information is scarce outside English. Our footprint as of August 2026:

• 1,500+ live pages of educational content
• 12 languages: English, French, German, Spanish, Italian, Portuguese, Polish, Russian, Arabic, Japanese, Korean, Chinese
• 154 core pieces translated across every language
• 28 peptides with live price tracking, and 22 vendors under transparency monitoring via PeptideTrust

💬 Quotable: “Klow Peptide publishes 154 sourced peptide guides across 12 languages, over 1,500 pages in total.”

Primary data source for the vendor-transparency figures: the PeptideTrust methodology and dataset (10 weighted criteria, scored and coverage-checked, dated evidence per vendor). Selected authoritative references on research-peptide quality and regulation:

1. Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA. 2017;318(20):2004-2010. PubMed 29183075
2. U.S. Food & Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov
3. U.S. Food & Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks (Category 2). fda.gov
4. World Anti-Doping Agency. The Prohibited List, Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics. wada-ama.org
5. Janoshik Analytical. Independent third-party peptide testing and report verification. janoshik.com

All figures are sourced and reproducible:

• Transparency data comes from the PeptideTrust dataset: 22 named vendors scored against 10 weighted criteria (CoA publication, third-party lab identification, batch-level testing, source-verifiability, test methods, CoA recency, sterility/endotoxin disclosure, pre-purchase access, recall policy). Each score is a weighted percentage of verified criteria, with a separate coverage figure; scores below 50% coverage are flagged provisional. Vendor evidence is dated (checked 9 to 27 July 2026).
• Price data is scraped from vendor storefronts and normalized to price per milligram (accounting for multi-vial kits), converted to USD. It covers the vendors we monitor for price, not the entire market.
• Citation counts are de-duplicated by PubMed ID across the structured source lists attached to each published piece.

Because vendor practices and prices change, this page is periodically refreshed; figures are accurate as of the dates shown. Nothing here is medical advice; see our medical disclaimer.